2017 Fiscal Year Final Research Report
Establishment of a novel regulating method for allogeneic or xenogeneic antibody-mediated rejection using a humanized mouse
| Project/Area Number |
15K10025
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
General surgery
|
|---|
| Research Institution | Hiroshima University |
|---|
Principal Investigator |
|
|---|
| Research Collaborator |
柳川 泉一郎 , 大学院生
|
|---|
| Project Period (FY) |
2015-04-01 – 2018-03-31
|
| Keywords | 異種移植 / 同種移植 / ヒト化マウス |
|---|
| Outline of Final Research Achievements |
In order to establish a HLA antibody-producing humanized mouse model using human cells, human peripheral blood was cultured in a culture system in which a transduction signal (CD40-CD40 ligand) for activating antibody-producing B cells was transfected, and HLA Antibody-producing humanized mice were born. However, only the target anti-donor- specific HLA antibody production was found to be inclined to inhibit production. Indicating the possibility of being a mouse model capable of verifying the mechanism of donor specific antibody production inhibition. Heterologous antibody-producing humanized mouse models could produce immunodeficient mice lacking heterologous antigens, but since they are not stable, humanized heterologous antibody-producing mouse models transfected with human cells have not been established yet.
|
| Free Research Field |
移植免疫
|
